Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor

被引:259
作者
Ashcroft, GS
Mills, SJ
Lei, KJ
Gibbons, L
Jeong, MJ
Taniguchi, M
Burow, M
Horan, MA
Wahl, SM
Nakayama, T
机构
[1] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
[2] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, NIH, Bethesda, MD USA
[3] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba, Japan
[5] Tulane Med Sch, New Orleans, LA USA
基金
英国惠康基金;
关键词
D O I
10.1172/KCO200316288
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Characteristic of both chronic wounds and acute wounds that fail to heal are excessive leukocytosis and reduced matrix deposition. Estrogen is a major regulator of wound repair that can reverse age-related impaired wound healing in human and animal models, characterized by a dampened inflammatory response and increased matrix deposited at the wound site. Macrophage migration inhibitory factor (MIF) is a candidate proinflammatory cytokine involved in the hormonal regulation of inflammation. We demonstrate that MIF is upregulated in a distinct spatial and temporal pattern during wound healing and its expression is markedly elevated in wounds of estrogen-deficient mice as compared with intact animals. Wound-healing studies in mice rendered null for the MIF gene have demonstrated that in the absence of MIF, the excessive inflammation and delayed-healing phenotype associated with reduced estrogen is reversed. Moreover, in vitro assays have shown a striking estrogen-mediated decrease in MIF production by activated murine macrophages, a process involving the estrogen receptor. We suggest that estrogen inhibits the local inflammatory response by downregulating MIF, suggesting a specific target for future therapeutic intervention in impaired wound-healing states.
引用
收藏
页码:1309 / 1318
页数:10
相关论文
共 44 条
[1]   Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts [J].
Abe, R ;
Shimizu, T ;
Ohkawara, AA ;
Nishihira, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (01) :1-9
[2]   Macrophage migration inhibitory factor in the human endometrium: Expression and localization during the menstrual cycle and early pregnancy [J].
Arcuri, F ;
Ricci, C ;
Ietta, F ;
Cintorino, M ;
Tripodi, SA ;
Cetin, I ;
Garzia, E ;
Schatz, F ;
Klemi, P ;
Santopietro, R ;
Paulesu, L .
BIOLOGY OF REPRODUCTION, 2001, 64 (04) :1200-1205
[3]   Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing [J].
Ashcroft, GS ;
Lei, KJ ;
Jin, WW ;
Longenecker, G ;
Kulkarni, AB ;
Greenwell-Wild, T ;
Hale-Donze, H ;
McGrady, G ;
Song, XY ;
Wahl, SM .
NATURE MEDICINE, 2000, 6 (10) :1147-1153
[4]   Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans [J].
Ashcroft, GS ;
Horan, MA ;
Herrick, SE ;
Tarnuzzer, RW ;
Schultz, GS ;
Ferguson, MWJ .
CELL AND TISSUE RESEARCH, 1997, 290 (03) :581-591
[5]   Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response [J].
Ashcroft, GS ;
Greenwell-Wild, T ;
Horan, MA ;
Wahl, SM ;
Ferguson, MWJ .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1137-1146
[6]   Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response [J].
Ashcroft, GS ;
Yang, X ;
Glick, AB ;
Weinstein, M ;
Letterio, JJ ;
Mizel, DE ;
Anzano, M ;
Greenwell-Wild, T ;
Wahl, SM ;
Deng, CX ;
Roberts, AB .
NATURE CELL BIOLOGY, 1999, 1 (05) :260-266
[7]   Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta 1 levels [J].
Ashcroft, GS ;
Dodsworth, J ;
vanBoxtel, E ;
Tarnuzzer, RW ;
Horan, MA ;
Schultz, GS ;
Ferguson, MWJ .
NATURE MEDICINE, 1997, 3 (11) :1209-1215
[8]   Is hormone replacement therapy protective for venous ulcer of the lower limbs? [J].
Bérard, A ;
Kahn, SR ;
Abenhaim, L .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (03) :245-251
[9]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[10]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&